Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuronal protection with magnesium.

G Gathwala1

  • 1Neonatology Unit, Department of Paediatrics, Pt. Baghwat Dayal Sharma PGIMS, Rohtak, India.

Indian Journal of Pediatrics
|June 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Third cerebellar hemisphere: an unusual new cerebellar anomaly.

AJNR. American journal of neuroradiology·2011
Same author

Acid-base disorders in critically ill neonates.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2010
Same author

Waardenburg syndrome Type II.

Kathmandu University medical journal (KUMJ)·2008
Same author

Human milk fortification and gastric emptying in the preterm neonate.

International journal of clinical practice·2008
Same author

Effect of adenotonsillitis on peak exploratory flow rate in children.

JNMA; journal of the Nepal Medical Association·2006
Same author

A study on plasma selenium level among pregnant women at Rohtak, Haryana.

Indian journal of public health·2004
Same journal

Bilateral Parotid Enlargement as an Initial Manifestation of Pediatric Acute Lymphoblastic Leukemia.

Indian journal of pediatrics·2026
Same journal

Hemorrhagic Cardiac Tamponade Due to MRSA Sepsis in a Child with Relapsed Acute Lymphoblastic Leukemia: Authors' Reply.

Indian journal of pediatrics·2026
Same journal

A Prospective Model for Detecting Missed Appendicitis in Low-Risk Pediatric Patients: Correspondence.

Indian journal of pediatrics·2026
Same journal

Serum Periostin as a Biomarker in Pediatric Asthma: Findings from a Case-Control Study - Authors' Reply.

Indian journal of pediatrics·2026
Same journal

When the Eye Peels: An Unusual Harbinger of Kawasaki Disease - Correspondence.

Indian journal of pediatrics·2026
Same journal

Pediatric Sleep-Related Laryngospasm: Cause of Nocturnal Respiratory Distress.

Indian journal of pediatrics·2026
See all related articles

Magnesium may protect newborns from brain damage after oxygen deprivation. Further clinical trials are needed to confirm if magnesium is a safe and effective neuroprotective treatment for neonates.

Area of Science:

  • Neuroscience
  • Neonatal Medicine
  • Pharmacology

Background:

  • Hypoxic ischemic insult can cause delayed neuronal death, primarily mediated by the N-methyl D-aspartate (NMDA) receptor.
  • NMDA receptor antagonists like MK-801 show neuroprotective effects but are too toxic for human neonates.
  • Magnesium is known to block the NMDA channel in a voltage-dependent manner.

Purpose of the Study:

  • To investigate the potential of magnesium as a neuroprotective agent in neonatal hypoxic ischemic injury.
  • To evaluate the efficacy of magnesium in limiting neurological damage following simulated hypoxic ischemic insults in animal models.

Main Methods:

  • Administration of magnesium following simulated hypoxic ischemic insult in animal models.
  • Assessment of neurological damage and neuronal death.

Related Experiment Videos

Main Results:

  • Magnesium administration limited neurological damage in several animal models of hypoxic ischemic injury.
  • Magnesium's voltage-dependent NMDA channel blocking action suggests a plausible mechanism for neuroprotection.

Conclusions:

  • Magnesium shows promise as a neuroprotective agent against hypoxic ischemic injury in preclinical models.
  • Controlled clinical trials are essential to establish the safety and efficacy of magnesium for neuroprotection in human neonates.